Skip to Main Content

Regulations

Current Regulations

Third (Final) Version of RegulationsDraft (Posted July 17, 2023)

COMMENT PERIOD CLOSED: June 30, 2023 (Posted: June 16, 2023)

COMAR 14.01.01.01 – General Provisions (Definitions) (Second Draft)

COMAR 14.01.01.01 – General Provisions (Definitions) (Redlined)

COMAR 14.01.01.02-.03 – General Provisions (Rules of Construction, Open Meetings) (Second Draft)

COMAR.01.01.02-.03 – General Provisions (Rules of Construction, Open Meetings) (Redlined)

COMAR 14.01.01.04 – General Provisions (Confidential, Trade-Secret, and Proprietary Information) (Second Draft)

COMAR. 14.01.0.1.04 – General Provisions (Confidential, Trade-Secret and Proprietary Information) (Redlined)

COMAR 14.01.04.01-05 – Cost Review Study Process (Second Draft)

COMAR 14.01.04.01-05 – Cost Review Study Process (Redlined)

Comments Received

Draft Regulations for Consideration at May 22, 2023 Board Meeting (Posted May 15, 2023)

COMAR 14.01.02.02-.03 – Prescription Drug Affordability Fund (Second Draft)

COMAR 14.01.02.02-.03 – Prescription Drug Affordability Fund (Redlined)

COMAR 14.01.03 Public Information Act (Second Draft)

COMAR 14.01.03 Public Information Act (Redlined)

COMMENT PERIOD CLOSED MAY 5, 2023 (Posted on April 24, 2023)

COMAR 14.01.01.02- Rules of Construction (First Draft)

COMAR 14.01.04.01- Public Information Act (First Draft)

COMAR 14.01.01.04 – Confidential, Trade-Secret, and Proprietary Information (First Draft)

COMMENT PERIOD CLOSED MAY 2, 2023 (Posted on April 11, 2023)

COMAR 14.01.01.01 – General Provisions (Definitions- NEW) (First Draft)

COMAR 14.01.02.02 – Prescription Drug Affordability Fund (First Draft)

COMAR 14.01.03.01-05 – Cost Review Process (First Draft)

Received Comments